Screener
PTC Therapeutics PTCT Total Assets
Total Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Goodwill | 82,341 | 82,341 |
| Operating lease ROU assets | 76,692 | 80,053 |
| Deposits and other assets | 22,645 | 18,301 |
| Total assets | $2,869,104 | $2,898,767 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $313,050 | $381,272 |
| Current portion of long-term debt | 286,937 | 286,631 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's total assets?
- PTC Therapeutics (PTCT) reported total assets of $2.87B in Q1 2026.
- How has PTC Therapeutics's total assets changed year-over-year?
- PTC Therapeutics's total assets increased by 8.0% year-over-year, from $2.66B to $2.87B.
- What is the long-term trend for PTC Therapeutics's total assets?
- Over 5 years (2020 to 2025), PTC Therapeutics's total assets has grown at a 5.6% compound annual growth rate (CAGR), from $2.21B to $2.9B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about PTC Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude